INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09969 INNOCARE

Market Closed 07-17 16:08:11

13.810

-0.880

-5.99%

High14.760	Low13.490	Vol15.73M
Open14.630	D1 Closing14.690	Amplitude8.65%
Mkt Cap24.40B	Tradable Cap20.63B	Total Shares1.77B
T/O217.82M	T/O Rate1.05%	Tradable Shares1.49B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"INNOCARE","latestPrice":13.81,"timestamp":1784275691009,"preClose":14.69,"halted":0,"volume":15728310,"delay":0,"changeRate":-0.0599046970728386,"floatShares":1494000000,"shares":1767000000,"eps":0.38,"marketStatus":"Market Closed","change":-0.88,"latestTime":"07-17 16:08:11","open":14.63,"high":14.76,"low":13.49,"amount":217816043,"amplitude":0.086453,"askPrice":13.81,"askSize":26000,"bidPrice":13.77,"bidSize":25000,"shortable":3,"etf":0,"ttmEps":0.469,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":7,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":14.69,"openAndCloseTimeList":[[1784251800000,1784260800000],[1784264400000,1784275200000]],"volumeRatio":1.2672547865713957,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"Innocare Pharma Limited","latestPrice":26.52,"timestamp":1784271600000,"preClose":29.21,"halted":0,"volume":24165400,"delay":0,"premium":"-54.99"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"1154417308","title":"Movement Alert｜InnoCare Pharma Falls 5.04% in Regular Trading, Biotech Sector Sell-Off Compounds Post-Catalyst Profit-Taking","url":"https://stock-news.laohu8.com/highlight/detail?id=1154417308","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154417308?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:55","pubTimestamp":1784256903,"startTime":"0","endTime":"0","summary":"On July 17, InnoCare Pharma declined 5.04% in regular trading, trading at HK$13.88/share, with turnover of HK$85.67 million.The decline comes as the broader biotechnology sector experienced a sharp...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651457384","title":"InnoCare Pharma's Phase II Study of Vitiligo Drug Shows Consistent Safety, Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2651457384","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651457384?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:46","pubTimestamp":1784198815,"startTime":"0","endTime":"0","summary":"InnoCare Pharma's  phase II portion of the ongoing phase II/III adaptive study of soficitinib met its primary endpoint.The drug showed meaningful improvements versus placebo for the treatment of adult patients with non-segmental vitiligo, according to a Thursday Hong Kong bourse filing.Treatment with the drug also demonstrated consistent efficacy across multiple secondary endpoints.The drug's safety profile is consistent with previous studies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","09969","BK1574","688428","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119468233","title":"Innocare's TYK2 Inhibitor Soficitinib Meets Primary Endpoint in Phase II Vitiligo Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1119468233","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119468233?lang=en_us&edition=fundamental","pubTime":"2026-07-16 16:47","pubTimestamp":1784191679,"startTime":"0","endTime":"0","summary":"Clinical trial results for Innocare Pharma Limited (ASX: 688428) show its investigational drug has successfully achieved its primary objective in a mid-stage study.The company announced that the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK0239","09969","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136106160","title":"Phase III Trial for Innocare's Atopic Dermatitis Drug Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1136106160","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136106160?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:03","pubTimestamp":1784113416,"startTime":"0","endTime":"0","summary":"Innocare has announced that its internally developed, novel oral tyrosine kinase 2 (TYK2) inhibitor, soficitinib (ICP-332), has successfully met the primary endpoint in its Phase III registration...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","III","688428","BK1574","BK1161","09969","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137000476","title":"Movement Alert｜InnoCare Pharma Rises 5.09% in Regular Trading, Biotech Sector Rallies as CDH17 ADC Clinical Data Published","url":"https://stock-news.laohu8.com/highlight/detail?id=1137000476","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137000476?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:57","pubTimestamp":1784080661,"startTime":"0","endTime":"0","summary":"On July 15, InnoCare Pharma rose 5.09% in regular trading, trading at HK$15.04 per share, with turnover of HK$67.34 million.The gain was driven by a broad-based rally in the biotech sector alongside...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651973109","title":"InnoCare Pharma (SEHK:9969) Is Up 6.6% After First CDH17 ADC Enters Human Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2651973109","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651973109?lang=en_us&edition=fundamental","pubTime":"2026-07-14 17:31","pubTimestamp":1784021502,"startTime":"0","endTime":"0","summary":"In July 2026, InnoCare Pharma reported that it had dosed the first patient in a Chinese clinical trial of ICP-B208, a novel in-house CDH17-targeted antibody-drug conjugate (ADC) designed with a proprietary payload and protease-cleavable linker for improved stability and safety.\nThis marks an early but important test of InnoCare’s ADC platform against CDH17, a tumor-restricted target relevant to multiple gastrointestinal cancers for which no CDH17 ADCs are yet approved globally.\nNext, we’ll...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-is-up-66-after-first-cdh17-adc-ente","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-is-up-66-after-first-cdh17-adc-ente","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4080","ADC.AU","ADC","09969","BK1161","BK7095","BK4231","NETL","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650580711","title":"Is InnoCare Pharma (SEHK:9969) Undervalued On Its Breakthrough Lupus Trial Results?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650580711","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650580711?lang=en_us&edition=fundamental","pubTime":"2026-07-11 05:34","pubTimestamp":1783719282,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (SEHK:9969) is back in focus after new clinical data showed its BTK inhibitor orelabrutinib was well tolerated and clinically effective in a large Phase IIb study for systemic lupus erythematosus.\nSee our latest analysis for InnoCare Pharma.\nAlongside the positive lupus data, InnoCare Pharma has also started dosing patients in China with its CDH17 targeted ADC ICP-B208. The stock’s recent momentum reflects this, with a 1 month share price return of 34.55% but a 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/is-innocare-pharma-sehk9969-undervalued-on-its-breakthrough","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/is-innocare-pharma-sehk9969-undervalued-on-its-breakthrough","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1161","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159004783","title":"Movement Alert｜InnoCare Pharma Rises 5.07% in Regular Trading, HK Innovative Drug Sector Rallies as ADC Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=1159004783","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159004783?lang=en_us&edition=fundamental","pubTime":"2026-07-10 11:18","pubTimestamp":1783653506,"startTime":"0","endTime":"0","summary":"On July 10, InnoCare Pharma rose 5.07% in regular trading, trading at HKD 14.06/share, with turnover of approximately HKD 74.04 million.On the news front, Hong Kong-listed innovative drug stocks...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133667142","title":"Innocare Pharma Shares Advance with Robust Quarterly Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1133667142","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133667142?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:40","pubTimestamp":1783597243,"startTime":"0","endTime":"0","summary":"The stock of Innocare Pharma Limited (ASX: 688428) closed higher today.At the time of writing, Innocare Pharma Limited (ASX: 688428) closed at 29.10 yuan, marking a gain of 4.49%. Trading volume...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","09969","BK1574","BK1161","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188490022","title":"Hong Kong Market Closes Higher, Healthcare and Tech Stocks Lead Gains While AI Hardware Sector Plunges","url":"https://stock-news.laohu8.com/highlight/detail?id=1188490022","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188490022?lang=en_us&edition=fundamental","pubTime":"2026-07-06 16:54","pubTimestamp":1783328072,"startTime":"0","endTime":"0","summary":"Hong Kong's stock market advanced in a choppy session on Friday, with all three major indices rising more than 1% at their intraday highs.The Hang Seng Index closed up 1.14% or 266.29 points at...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0315179316.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU0106959298.USD","LU2293587155.HKD","LU1008478684.HKD","LU0651947912.USD","SG9999001069.SGD","LU0823426308.USD","LU0890818403.SGD","LU1282651121.HKD","LU0572939691.SGD","03037","LU0531970944.HKD","07500","BIDD","LU0898667661.SGD","LU1048588211.SGD","LU0254981946.USD","LU2097828557.USD","LU1152091168.USD","LU1051769294.HKD","LU0823041008.USD","LU0499858602.USD","HK0000352382.USD","LU0882747503.HKD","LU0871576103.HKD","LU0029875118.USD","SG9999000418.SGD","IE0008368742.USD","LU1044874839.SGD","LU2488822045.USD","LU0577902611.USD","LU0972618739.USD","LU2039709279.SGD","LU1023057109.AUD","03419","IE0008369823.USD","LU0329678337.USD","LU1282651048.USD","LU1733274390.USD","KCAI","LU2237443895.HKD","SG9999001093.SGD","LU1048596156.SGD","LU0441854154.USD","LU2362540622.SGD","LU2476274720.SGD","LU0577902538.SGD","LU0261950983.USD","LU1807302812.USD","LU1868837565.USD","QTOC","LU0314109678.HKD","TCHI","LU0320764599.SGD","LU0828237940.HKD","LU0651946864.USD","LU0345775950.USD","MCHS","LU0348783662.USD","LU1688375341.USD","SG9999014898.SGD","SG9999002562.SGD","LU0261947096.USD","LU0456846285.SGD","LU0348783233.USD","LU0588545730.USD","LU2187417386.USD","HK0000151867.HKD","BK1618","LU0675040207.SGD","LU1568876251.USD","LU1282649141.HKD","LU0259732245.USD","LU0328353924.USD","LU0878004406.USD","LU1770034418.SGD","IE00BF5LJ272.USD","LU0345769631.USD","LU0708995153.HKD","LU2045819591.USD","LU0235996351.USD","LU0577902371.SGD","LU0048580855.USD","LU0417516902.SGD","LU0029874905.USD","LU2148510915.USD","LU0608807946.USD","LU0823039010.USD","LU0633140560.USD","LU1733274473.HKD","LU0287142896.SGD","LU0345769128.USD","02800","LU0700851271.USD","LU1568876335.HKD","IE0034224299.USD","LU0516422952.EUR","LU0588545490.SGD","LU1226288097.SGD","LU1769817096.USD","LU0396098781.USD","LU0823413660.USD","LU1883866441.USD","LU1046422090.SGD","LU0072913022.USD","LU1951186391.HKD","SG9999001051.SGD","LU0067412154.USD","LU2247934214.USD","LU0463099449.HKD","LU0607220059.USD","LU0051755006.USD","IE00B0169L03.USD","ESPO","LU2125910849.SGD","LU0348814723.USD","LU0985320562.USD","SG9999001846.SGD","LU2152927971.USD","LU0047713382.USD","IE0003795394.USD","LU0370786039.SGD","IE0031814852.USD","LU0149721374.USD","LU0449515922.USD","LU0589944569.HKD","LU2449936058.SGD","LU0455707207.USD","LU1439102457.SGD","SG9999015986.USD","BK1502","IE0032431581.USD","LU2177674079.SGD","LU2251237306.USD","LU0831103253.SGD","LU2265009873.SGD","LU0049112450.USD","LU0039217434.USD","LU0821914370.USD","LU0011963245.USD","BK1095","LU0049853897.USD","LU2051468812.USD","BK1521","LU2257852520.SGD","BK1515","IE00B067MR52.USD","LU1242518931.SGD","LU0737861772.HKD","513600","TCHmain","LU0862451753.SGD","LU0106252389.USD","LU3227948356.SGD","SG9999017495.SGD","LU0269904917.USD","VTHR","LU1242518857.USD","IE0003851619.USD","159938","LU1880383440.USD","82800","LU1808992512.USD","LU0650527681.SGD","LU1961090484.USD","LU0107464264.USD","LU0192582467.USD","LU0359201885.HKD","LU0588546209.SGD","BK1589","IE00B0169N27.USD","SG9999003461.SGD","LU1282648689.USD","LU0828238088.HKD","LU0784639295.USD","SG9999001689.USD","LU2242644610.SGD","LU2251237488.HKD","ODDS","BK1610","LU1224444064.USD","LU0738912210.USD","LU0873338254.USD","IE00B031HY20.USD","LU1226287792.SGD","LU2279701549.SGD","01112","SG9999013353.USD","LU0359202008.SGD","09115","LU2317271919.USD","LU0054450605.USD","LU0540923850.HKD","SG9999000327.SGD","LU0488056044.USD","HK0001040143.USD","LU0593848301.USD","02833","LU2008162690.USD","BKF","CHAT","LU0175139822.USD","LU0127658192.USD","HK0001040168.HKD","IE00BGV7N243.SGD","LU0164880469.USD","IE00BQXX3D17.EUR","LU1868837722.USD","07300","LU0326948709.USD","LU2498475776.HKD","LU0359201612.USD","LU2237443465.HKD","LU2294711473.HKD","AAXJ","BK1161","LU0588545904.SGD","MCHmain","IE0008368411.USD","LU1226287529.USD","03115","LU0117844026.USD","LU0228659784.USD","LU0577902454.USD","LU1152091754.HKD","LU1504937902.USD","LU0541502299.USD","LU0320764755.SGD","83115","LU0531971595.HKD","LU2087589342.USD","BK1170","LU0169518387.USD","IE00BZ08YT58.USD","LU1102505762.USD","SGXZ31699556.SGD","LU1917777945.USD","LU0823397103.USD","SG9999015978.USD","LU0251144936.SGD","LU1366334578.USD","LU0469268626.HKD","LU0196878994.USD","BK1506","SOCL","IE0009570106.USD","BK1517","LU0348723411.USD","ARTY","LU0865486749.SGD","LU0210533765.USD","AGIX","LU1642822792.SGD","SG9999018865.SGD","LU1196710351.USD","LU0791590937.USD","LU0868486357.SGD","SG9999014906.USD","LU0070217475.USD","LU0856984785.SGD","09969","LU0878005551.USD","LU0348735423.USD","LU1328277881.USD","LU0164872284.USD","LU0456827905.SGD","LU0543330483.HKD","LU0823038988.USD","IE00BQXX3F31.USD","LU0384037296.USD","LU2351347302.SGD","LU0516423091.SGD","LU0293314216.USD","LU0672654166.SGD","LU0080751232.USD","LU1044875133.USD","LU0315178854.USD","LU0173614495.USD","IE00BZ08YS42.EUR","LU0594300179.USD","BK1574","LU0819121731.USD","LU1251922891.USD","LU1718418525.SGD","LU1868838027.USD","IE00B5MMRT66.SGD","BK1553","LU0502904849.HKD","LU2097828631.EUR","LU0140636845.USD","LU0786609619.USD","LU0417516571.SGD","LU2362541273.HKD","LU0572944931.SGD","SG9999001226.SGD","LU0264606111.USD","LU0640798160.USD","KWEB","IE00BZ08YR35.GBP","LU1813983027.USD","LU1804176565.USD","SG9999015945.SGD","BK1591","LU0348827113.USD","BK1237","LU1064130708.USD","HSImain","JADE","SGXZ90724238.SGD","LU3063872942.SGD","LU0509642566.USD","LU1224709979.USD","BK1516","LU0594300419.USD","LU0414403682.SGD","LU1439103000.SGD","SG9999015952.SGD","LU1282649067.USD","IE00B3M56506.USD","LU0326950275.SGD","LU1051768304.USD","IE00BQXX3C00.GBP","LU0231483743.USD","LU1956131251.USD","BK1609","LU0143863784.USD","LU0149534421.HKD","LU2226246903.HKD","LU0634319403.HKD","LU1282649810.SGD","AIPO","LU0348825331.USD","LU0244354667.USD","LU1725190679.HKD","LU0164865239.USD","LU0203347892.USD","LU1303224171.USD","LU1196710195.USD","HSI","BK4585","BK1608","LU0289960550.SGD","IE00B031J352.USD","LU0791591158.USD","LU1770036033.HKD","MHImain","LU1720050803.USD","LU1981816686.USD","LU1675838814.USD","CXSE","IE00BPRC5H50.USD","LU0132412106.USD","LU0683595622.HKD","LU2462611646.USD","LU0823397285.USD","LU0886674414.USD","LU0577902298.EUR","LU1734074674.USD","HTCD.SI","HK0000914686.HKD","LU0823426480.USD","SGXZ99366536.SGD","LU1993786604.SGD","LU0210527791.USD","LU0128522157.USD","LU0823413587.USD","LU1226288253.USD","HHImain","IE00B8HQ1Z84.USD","LU0543330566.HKD","LU0648948544.HKD","LU2237443549.SGD","IE0001KFT4U8.USD","IE00B0JY6N72.USD","LU0797268264.HKD","SG9999000459.SGD","LU1064131003.USD","LU1366334651.USD","LU1323998911.USD","LU1188198961.HKD","HK0000352291.HKD","LU0096374516.USD","LU0828237510.HKD","LU0979878070.USD","LU0228367735.SGD","JEMA","LU0143863198.USD","LU1226288170.HKD","SG9999007991.SGD","LU1794554557.SGD","LU1105468828.SGD","LU0052750758.USD","LU0516422366.SGD","LU0054237671.USD","LU0084288322.USD","LU0348805143.USD","LU1328615791.USD","LU0516423174.USD","LU0737861699.HKD","SG9999001903.USD","LU0823040885.USD","LU0348788117.USD","LU0061477393.USD","HK0000320223.HKD","FPA","LU1235295612.USD","LU1316542783.SGD","LU1655091459.SGD","LU2237443382.USD","LU0819123356.HKD","LU2133065610.SGD","LU0165289439.USD","LU2778985437.USD","FDNI","LU1691799644.USD","LU2237443622.USD","LU2023250504.SGD","IE00B29SXG58.USD","LU0043850808.USD","LU1196710864.SGD","LU0211977185.USD","LU1211504680.USD","LU0348816934.USD","LU0329678170.USD","HK0000914660.USD","BK1526","09939","LU2399975544.HKD","LU1960683339.HKD","LU0918141705.HKD","IE00B97KM107.HKD","BK1615","LU1880383366.USD","LU0203345920.USD","LU0348784397.USD","SG9999006597.SGD","LU0417516738.SGD","SGXZ81514606.USD","BK1597","LDEM","LU0516422440.USD","LU1115378108.SGD","LU2097828714.EUR","HK0000320264.USD","LU0708995583.HKD","LU0499858438.USD","LU2476274308.USD","LU0048597586.USD","LU0862451837.USD","IE00B031HW06.USD","LU1810669033.SGD","LU2929501877.USD","LU0449509016.USD","LU1629966141.USD","LU0431992006.USD","LU0880133367.SGD","LU2237443978.SGD","SG9999002463.SGD","LU0633140727.USD","LU2097828805.USD","SG9999002828.SGD","02419","SG9999014674.SGD","LU0229945570.USD","LU0572940350.SGD","LU0163747925.USD","LU1481107354.HKD","LU1102505929.USD","LU0072462343.USD","LU0214875030.USD","LU0345776255.USD","LU1974910355.USD","SG9999014880.SGD","LU0307460666.USD","VXUS","SGXZ51526630.SGD","LU0541501648.USD","LU0561508036.HKD","BK4588","07200","01888","IE0032834883.USD","HK0000306701.USD","LU2362541513.USD","LU1044876610.USD","FFEM","LU0327786744.USD","GB00BDT5M118.USD","HK0000306685.HKD","IE00B8L5B284.USD","SG9999014914.USD","LU0456842615.SGD","LU0918141887.USD","LU1226287875.USD","LU2125910500.SGD","LU0611395673.USD","BK1531","LU1515016050.SGD","LU0188438112.USD","SG9999018857.SGD","XSOE","LU1785774172.SGD","LU0128522744.USD","LU1814569148.SGD","LU2106854487.HKD","LU0117841782.USD","LU0608807433.USD","LU1769817179.HKD","00700","IE0003895053.USD","LU0320764243.SGD","LU2097828474.EUR","LU1719994722.HKD","LU1831875114.USD","LU0048388663.USD","LU0642271901.SGD","LU0210526637.USD","LU0106259558.USD","LU0211331839.USD","EMC","BK1586","SG9999004220.SGD","LU0181495838.USD","LU1048484197.HKD","SG9999006514.SGD","LU0605514214.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133721592","title":"Biopharma Stocks Continue to Rally in Early Trading Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1133721592","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133721592?lang=en_us&edition=fundamental","pubTime":"2026-07-06 11:00","pubTimestamp":1783306840,"startTime":"0","endTime":"0","summary":"Shares within the biopharmaceutical sector maintained their upward momentum during the morning session.At the time of writing, SBP GROUP (ASX: 01177) shares had advanced by 10.76% to HK$5.25.INNOCARE...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1589","BK1574","BK1515","BK1161","01177","09969","688428","BK1191","BK1521","HK0000165453.HKD","IBBQ","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK0239","159992","IE00BZ08YR35.GBP","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131894691","title":"Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization","url":"https://stock-news.laohu8.com/highlight/detail?id=1131894691","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131894691?lang=en_us&edition=fundamental","pubTime":"2026-07-06 10:10","pubTimestamp":1783303836,"startTime":"0","endTime":"0","summary":"The innovative drug concept continued its upward trend in Hong Kong trading.Innocare (09969) rose 7.95% to HK$14.12, SBP GROUP (01177) gained 7.38% to HK$5.09, and KEYMED BIO-B (02162) advanced 7.01%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","01801","06978","LU0314109678.HKD","LU1152091168.USD","IE00BZ08YR35.GBP","BK1574","LU0326950275.SGD","BK1515","LU1328277881.USD","IBBQ","IE00BZ08YT58.USD","02162","VXUS","LU1807302812.USD","BK1583","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU0315179316.USD","BK1161","LU1008478684.HKD","LU1813983027.USD","HK0000165453.HKD","LU2097828474.EUR","LU2097828557.USD","LU2242644610.SGD","01093","LU0140636845.USD","01177","BK1521","LU1226287875.USD","LU1951186391.HKD","BK1587","KCAI","159992","LU0067412154.USD","LU0072913022.USD","LU1226287792.SGD","09969","LU0502904849.HKD","BK4588","BK4585","LU2097828805.USD","SG9999004220.SGD","LU0501845795.SGD","LU1960683339.HKD","LU1226287529.USD","BK1589","BK1191","LU1152091754.HKD","LU1969619763.USD","LU1226288253.USD","LU2328871848.SGD","KURE","IE0008368742.USD","LU2097828714.EUR","LU0880133367.SGD","LU2488822045.USD","MEDX","IE0008369823.USD","LU0455707207.USD","LU2039709279.SGD","IE00B031HY20.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117757580","title":"Innocare's Stock Surges Over 9% as First Patient Dosed with Novel In-house Developed CDH17-Targeting ADC Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1117757580","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117757580?lang=en_us&edition=fundamental","pubTime":"2026-07-06 10:00","pubTimestamp":1783303238,"startTime":"0","endTime":"0","summary":"Shares of Innocare (09969) surged more than 9% during intraday trading. At the time of writing, the stock was up 6.42% to HK$13.92, with a turnover of HK$542.69 million. On July 6th, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","MEDX","ADC","688428","BK0239","BK4231","09969","BK1574","BK4080","BK1161","NETL","IBBQ","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120897847","title":"Movement Alert｜InnoCare Pharma Rises 6.65% in Regular Trading, Self-Developed ADC Drug ICP-B208 Completes First Patient Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=1120897847","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120897847?lang=en_us&edition=fundamental","pubTime":"2026-07-06 10:00","pubTimestamp":1783303230,"startTime":"0","endTime":"0","summary":"On July 6, InnoCare Pharma (09969.HK) rose 6.65% in regular trading, trading at HK$14.03/share, with turnover of HK$72.80 million.On the news front, InnoCare Pharma announced that its self-developed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149233574","title":"Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149233574","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149233574?lang=en_us&edition=fundamental","pubTime":"2026-07-06 09:58","pubTimestamp":1783303082,"startTime":"0","endTime":"0","summary":"Hong Kong innovative drug stocks jumped in market trading. $HAIXI PHARMA(02637)$, $INNOCARE(09969)$ up 7%; $KEYMED BIO-B(02162)$ up 5%; $REMEGEN(09995)$, $INNOVENT BIO(01801)$, $SIMCERE PHARMA(02096)$ up 4%; $LEPU BIO(02157)$ up 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157","09995","09969","02096","02162","01801","SOXL","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199774060","title":"Innocare Shares Surge Over 8% Following First Patient Dosing of Novel In-House ADC Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1199774060","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199774060?lang=en_us&edition=fundamental","pubTime":"2026-07-06 09:48","pubTimestamp":1783302508,"startTime":"0","endTime":"0","summary":"Shares of Innocare (HKEX: 09969) have surged more than 8%. At the time of writing, the stock is up 8.72% to HK$14.2, with a trading turnover of HK$45.1052 million. The catalyst for the move is an...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK0239","KCAI","BK4588","MEDX","BK4585","BK4231","06978","ADC","BK1574","159992","IBBQ","VXUS","688428","09969","NETL","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188353932","title":"InnoCare issues 1.91 million RSUs under 2023 Share Award Scheme, equal to 0.11% of share capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1188353932","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188353932?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:24","pubTimestamp":1782822298,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited announced that on 30 June 2026 its Board granted 1.91 million restricted share units (RSUs) to eight employees under the 2023 Share Award Scheme, representing about 0.11% of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136749555","title":"Innocare Pharma Issues 2.42 Million New Shares Under 2024 Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1136749555","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136749555?lang=en_us&edition=fundamental","pubTime":"2026-06-26 17:19","pubTimestamp":1782465596,"startTime":"0","endTime":"0","summary":"Innocare Pharma Limited (HKEX: 09969) has announced the issuance of new shares pursuant to its 2024 equity incentive plan.On June 26, 2026, the company issued 795,000 new shares to two directors as a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MUCmain","CNHmain","UCmain","CYB","BK0239","BK1161","688428","BK1574","09969","MCNHmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645252940","title":"Extensive Orelabrutinib Data Across Regions Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645252940","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645252940?lang=en_us&edition=fundamental","pubTime":"2026-06-22 17:22","pubTimestamp":1782120162,"startTime":"0","endTime":"0","summary":"In June 2026, InnoCare Pharma reported that over 40 clinical studies of its BTK inhibitor orelabrutinib were presented at the European Hematology Association Congress, highlighting consistent efficacy and safety across multiple blood cancers and patient populations in the United States, Europe, and China.\nBeyond confirming strong responses in chronic lymphocytic leukemia and marginal zone lymphoma, the data suggested orelabrutinib may offer a differentiated safety profile and meaningful...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/extensive-orelabrutinib-data-across-regions-might-change-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/extensive-orelabrutinib-data-across-regions-might-change-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","CHAT","LU1880398471.USD","BK1574","BK4211","BK1161","RF","LU1883839398.USD","AGIX","AIPO","BK4588","LU1880398554.USD","BK4585","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645809471","title":"InnoCare Pharma (SEHK:9969) Stock Could Be 45% Undervalued After EHA 2026 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2645809471","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645809471?lang=en_us&edition=fundamental","pubTime":"2026-06-21 13:24","pubTimestamp":1782019485,"startTime":"0","endTime":"0","summary":"Why InnoCare Pharma Stock Is In Focus After EHA 2026\nInnoCare Pharma (SEHK:9969) has drawn fresh attention after presenting data from more than 40 clinical studies of its BTK inhibitor orelabrutinib at the European Hematology Association 2026 Congress.\nThe company highlighted outcomes across several hematological cancers, including chronic lymphocytic leukemia, small lymphocytic lymphoma, marginal zone lymphoma, mantle cell lymphoma, diffuse large B cell lymphoma, and primary central nervous...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-stock-could-be-45-undervalued-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-stock-could-be-45-undervalued-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":0.3343},{"period":"3month","weight":-0.1215},{"period":"6month","weight":0.0672},{"period":"1year","weight":-0.2429},{"period":"ytd","weight":0.1228}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0103},{"period":"3month","weight":-0.0611},{"period":"6month","weight":-0.085},{"period":"1year","weight":0.0026},{"period":"ytd","weight":-0.0417}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.103999},{"month":2,"riseRate":0.666667,"avgChangeRate":0.128923},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.010195},{"month":4,"riseRate":0.714286,"avgChangeRate":0.102464},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.059233},{"month":6,"riseRate":0.857143,"avgChangeRate":0.113731},{"month":7,"riseRate":0.571429,"avgChangeRate":0.057138},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.082108},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033299},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012645}],"exchange":"SEHK","name":"INNOCARE","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INNOCARE,09969,INNOCARE股票,INNOCARE股票老虎,INNOCARE股票老虎国际,INNOCARE行情,INNOCARE股票行情,INNOCARE股价,INNOCARE股市,INNOCARE股票价格,INNOCARE股票交易,INNOCARE股票购买,INNOCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}